CLINICAL_TRIALS
trial_result
· 2011-10-21
Clinical Trial Update: Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria [Phase 2]
Summary
Phase 2 study evaluating the efficacy and safety of omalizumab in adults aged 18-70 with moderate to severe chronic urticaria; the trial is completed with resul…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Chronic Urticaria | Phase 2 | Status: COMPLETED | Results posted: 2011-10-21